Dr. Hang Liu is a passionate biomedical researcher dedicated to bridging biomaterials innovation with translational cell therapies. His research develops designer biomaterial platforms for (1) cell-based therapeutics and (2) 3D disease models for high-throughput drug screening. By integrating principles from materials science, mechanobiology, and high-precision manufacturing, his work addresses critical challenges in regenerative medicine and pharmaceutical development.

刘航博士是一位专注于生物医学交叉领域的研究者，长期致力于推动生物材料创新与临床细胞治疗的融合。他的研究聚焦于构建新型生物材料平台，主要应用于两大方向：（1）开发细胞治疗新技术；（2）建立用于高通量药物筛选的三维疾病模型。通过整合材料科学、力学生物学与精密制造技术，他的研究旨在突破再生医学与新药研发中的关键瓶颈。

Dr. Liu’s multidisciplinary approach stems from training across science (PhD, NUS), cell biology (Postdoc, A*STAR IMCB), and clinical collaboration (Postdoc, School of Medicine, NUS). He has contributed to 21 peer-reviewed publications and secured funding as principal investigator from NUS Medicine and Merck Singapore. His lab welcomes students passionate about 3D cell culture, stem cell therapies, and bioactive molecules aimed at improving human health.

刘博士具有多元化的学术训练背景：他在新加坡国立大学取得博士学位后，于新加坡科技研究局分子细胞生物学研究所从事细胞生物学研究，同时于新加坡国立大学医学院从事临床转化方向的博士后研究工作。他已累计发表学术论文21篇，并作为项目负责人获得新加坡国立大学医学院及默克新加坡的科研资助。他的实验室诚邀对细胞治疗、三维细胞培养、生物活性分子与人类健康等领域感兴趣的学生和研究人员加入。